The Biostatistics Core provides stafisfical collaborafion and data management support for each of the SPORE projects, the Developmental Research Program projects, the Career Development Program, and the other Cores. The Biostafistics Core prepared the stafisfical plans for each of the four projects, will provide data management for each of the projects and adverse event monitoring for the clinical trials, and will prepare data summaries for manuscript preparation. The Biostatistics Core has been very active in preparing the stafistical plans for each of the four projects in this SPORE Application. Each of the projects presented in this applicafion reflects input from members of the Biostatistics Core on study design and analysis plan. These projects require a wide range of approaches and analyses. The Biostafistics Core builds upon the innovative and time-tested procedures and systems developed by Mayo Clinic, one of the largest stafisfical groups in the country whose members have collaborated on more than 13,000 clinical and basic science research studies since 1966. The Biostafistics Core has the capability to provide statistical support across different fields. Including molecular epidemiologic studies, basic science with translational, immunologic, and correlafive studies, gene microarray, clinical trials, gene and mutation discovery, and informafion management. The comprehensive nature of the Biostafisfics Core assures each SPORE invesfigator access to statistical expertise that includes collaborative development of study designs and analysis plans, state-of-the-art data analysis and Interpretation, data management resources, and abstract and manuscript preparation. The Biostafisfics Core also provides a mechanism for the management and integration of both existing and newly collected data through consistent and compatible data handling. Areas of support include database development, data form development and processing, data collecfion and entry, data archiving, quality control, and management of information relafing to the projects and cores. This Core complements and assists the efforts of the Animal Model Core and the Biospecimens and Patient Registry Core by providing superior data management and experience with fissue registries. The strengths of the Biostatistics Core are our collaboration with each of the projects and cores, the knowledge of and ability to ufilize the established research databases, the operational and statistical infrastructure already in place in the institution, and the breadth of expertise provided by Biostatistics Core personnel.

Public Health Relevance

Careful data management approaches and proper data analysis methods are required to ensure that the correct conclusions are made from a research study. The Biostafistics Core will provide expertise and support to ovarian cancer researchers in the areas of study design, data management, and data analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA136393-04
Application #
8380549
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
4
Fiscal Year
2012
Total Cost
$204,874
Indirect Cost
$66,488
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Wahner Hendrickson, Andrea E; Menefee, Michael E; Hartmann, Lynn C et al. (2018) A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors. Clin Cancer Res 24:744-752
Natanzon, Yanina; Goode, Ellen L; Cunningham, Julie M (2018) Epigenetics in ovarian cancer. Semin Cancer Biol 51:160-169
Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6
Jung, DeokBeom; Khurana, Ashwani; Roy, Debarshi et al. (2018) Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer. Sci Rep 8:2487
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Kalli, Kimberly R; Block, Matthew S; Kasi, Pashtoon M et al. (2018) Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients. Clin Cancer Res 24:3014-3025
Zhang, Qing; Wang, Chen; Cliby, William A (2018) Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer. Gynecol Oncol :
Morehead, Lauren C; Cannon, Martin J (2018) Further clinical advancement of dendritic cell vaccination against ovarian cancer. Ann Res Hosp 2:
Botuyan, Maria Victoria; Cui, Gaofeng; Drané, Pascal et al. (2018) Mechanism of 53BP1 activity regulation by RNA-binding TIRR and a designer protein. Nat Struct Mol Biol 25:591-600

Showing the most recent 10 out of 294 publications